Skip to content

30 million Americans have chronic tendon pain

Tendinopathy is a type of overuse injury, where the tendon is repeatedly strained until tiny tears form — most commonly involving the rotator cuff, medial and lateral elbow epicondyles, patellar tendon, and Achilles tendon.


The Ocelot™ Nano


Microinvasive technology designed to help a doctor perform percutaneous tenotomy.

The Ocelot Nano is indicated for fragmentation and debridement of soft tissue.  It can be used in percutaneous tenotomy to help disrupt scar tissue associated with tendinopathy. The idea is to reinjure the diseased  tendon using a powered cutting tip so the tendon can restart the healing process and heal properly. It’s less expensive and less invasive than alternative procedures and can be performed in an ambulatory surgical center, hospital or physician office.


“After 15 years of treating elite and recreational athletes for tendinopathy, I have been frustrated by the tools we have had to help heal these injuries. TendoNova’s Ocelot Nano will be a game changer in getting our athletes back to the healthiest level possible.”

Kenneth Mautner, MD

Head Team Physician of Atlanta Hawks and
Assoc. Professor Physiatry at Emory University School of Medicine

Widely recognized by

NFLPA logo
NFL 1st and Future logo
techout logo

“We believe investments in companies such as TendoNova are a crucial part of the NFLPA’s mission to improve the health, safety and well-being of players both on and off the field. TendoNova’s Ocelot Nano will help players from all levels of the game overcome nagging injuries so they don’t become lifelong problems.”

Sean Sansiveri

Oversees the NFLPA’s health, safety and medical research initiatives

TendoNova™ in the news

TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool

ATLANTAMarch 23, 2022 /PRNewswire/ —  TendoNova, an emerging leader in microinvasive sports medicine procedures, is pleased to announce the FDA 510(k) clearance of its new Ocelot surgical tool, which uses an innovative technology for fragmentation or debridement of soft tissue.

NFLPA Invests in TendoNova to Develop Devices that Enable Microinvasive Orthopedic Procedures

ATLANTA, June 11, 2020 (GLOBE NEWSWIRE) — The NFL Players Association (NFLPA), through its for-profit subsidiary NFL Players Inc., has invested in TendoNova™ Corporation. TendoNova is an Atlanta-based company that develops medical devices that enable microinvasive orthopedic procedures.